Health

Scientists reveal the stem cell stress response that links gray hair and melanoma.

The FDA has issued a recall of over 140,000 bottles of cholesterol medication due to "failed dissolution specifications." Here's the list.

Children with specialized medical needs celebrated Halloween early at St. Christopher's Hospital for Children in North Philadelphia.

A study from the American Heart Association and Brigham and Women’s Hospital finds that sleep patterns vary by state, with differences in how long and when people sleep.

Vizz is a recently FDA approved eye drop that can help people who struggle with near vision.

Boothwyn Pharmacy in Chester County is facing a $1 million fine for compounding GLP-1 medications in uninspected facilities.

A new study published in Nature Climate Change reveals that warmer weather may be increasing Americans’ sugar intake.

A new study led by the University of Oxford, in collaboration with Yale and Cambridge, suggests that even small amounts of alcohol consumption may increase the risk of dementia in older adults.

Changing advice on when to introduce young children to peanuts helped tens of thousands of kids avoid the allergy, a newly-published study found.

For the first time in over a decade, the number of states with rates of obesity at 35% or higher has dropped, according to a recent report.

The Neshaminy High School community is grappling with the sudden loss of senior Ryan Duffy who passed away due to bacterial meningitis.

Women seeking fertility treatment are getting financial relief after the Trump administration reached a deal with pharmaceutical company EMD Serono to lower the cost of a common fertility medication.

A new Consumer Reports investigation found protein powders and shakes have a concerning level of lead. Here are the products that were tested and what CR found.

After spinal cord injury, a Pennsylvania man's mobility continues to improve with an experimental peptide drug.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their lifetime.